Patents by Inventor Michael Lucero

Michael Lucero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210368911
    Abstract: A material is disclosed herein that may include a plurality of chambers. A wall, a bottom surface, and a top surface may define a chamber. The wall may have a top portion and a bottom portion where the top portion may be adjacent to the top surface, and the bottom portion may be adjacent to the bottom surface. The wall may include an elastic material, and an aerogel powder or an aerogel foam may be disposed within the chamber. This material can be incorporated into clothing and shoes, for example.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 2, 2021
    Applicant: Defy, LLC
    Inventor: Michael Lucero
  • Publication number: 20190169676
    Abstract: A method for carrying out nucleic acid amplification reactions using a microfluidic device is described. Amplification primers and other amplification reagents are deposited at a plurality of reaction sites in the device, a sample solution containing amplifiable polynucleotides is introduced into the reaction sites, and amplification is carried out.
    Type: Application
    Filed: October 2, 2018
    Publication date: June 6, 2019
    Inventors: Marc Unger, Ian D. Manger, Michael Lucero, Yong Yi, Emily Miyashita-Lin, Anja Wienecke, Geoffrey Facer
  • Patent number: 10131934
    Abstract: A method for carrying out nucleic acid amplification reactions using a microfluidic device is described. Amplification primers and other amplification reagents are deposited at a plurality of reaction sites in the device, a sample solution containing amplifiable polynucleotides is introduced into the reaction sites, and amplification is carried out.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: November 20, 2018
    Assignee: Fluidigm Corporation
    Inventors: Marc Unger, Ian D. Manger, Michael Lucero, Yong Yi, Emily Miyashita-Lin, Anja Wienecke, Geoffrey Facer
  • Publication number: 20180073051
    Abstract: A method for carrying out nucleic acid amplification reactions using a microfluidic device is described. Amplification primers and other amplification reagents are deposited at a plurality of reaction sites in the device, a sample solution containing amplifiable polynucleotides is introduced into the reaction sites, and amplification is carried out.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 15, 2018
    Inventors: Marc Unger, Ian D. Manger, Michael Lucero, Yong Yi, Emily Miyashita-Lin, Anja Wienecke, Geoffrey Facer
  • Patent number: 9643178
    Abstract: A variety of elastomeric-based microfluidic devices and methods for using and manufacturing such devices are provided. Certain of the devices have arrays of reaction sites to facilitate high throughput analyzes. Some devices also include reaction sites located at the end of blind channels at which reagents have been previously deposited during manufacture. The reagents become suspended once sample is introduced into the reaction site. The devices can be utilized with a variety of heating devices and thus can be used in a variety of analyzes requiring temperature control, including thermocycling applications such as nucleic acid amplification reactions, genotyping and gene expression analyzes.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: May 9, 2017
    Assignee: Fluidigm Corporation
    Inventors: Marc Unger, Ian D. Manger, Michael Lucero, Yong Yi, Emily Miyashita-Lin, Anja Wienecke, Geoffrey Facer
  • Patent number: 9644235
    Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: May 9, 2017
    Assignee: Fluidigm Corporation
    Inventors: Michael Lucero, Marc Unger
  • Publication number: 20160129441
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: October 2, 2015
    Publication date: May 12, 2016
    Inventors: Lincoln McBride, Geoffrey Facer, Marc Unger, Michael Lucero, Hany Ramez Nassef
  • Publication number: 20160108460
    Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.
    Type: Application
    Filed: July 27, 2015
    Publication date: April 21, 2016
    Inventors: Michael Lucero, Marc Unger
  • Patent number: 9150913
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: October 6, 2015
    Assignee: Fluidigm Corporation
    Inventors: Lincoln McBride, Geoffrey Facer, Marc Unger, Michael Lucero, Hany Ramez Nassef
  • Patent number: 9103825
    Abstract: A microfluidic device adapted to perform many simultaneous binding assays including but not limited to immunological experiments, such as ELISA assays, with minimal cross-talk between primary and secondary antibodies.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: August 11, 2015
    Assignee: FLUIDIGM CORPORATION
    Inventors: Hany Ramez Nassef, Hou-Pu Chou, Michael Lucero, Andrew May, Kathy Yokobata
  • Patent number: 9090934
    Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: July 28, 2015
    Assignee: Fluidigm Corporation
    Inventors: Michael Lucero, Marc Unger
  • Publication number: 20150031034
    Abstract: This invention provides compositions and methods for detecting differences in copy number of a target polynucleotide. In some cases, the methods and compositions provided herein are useful for diagnosis of fetal genetic abnormalities, when the starting sample is maternal tissue (e.g., blood, plasma). The methods and materials described apply techniques for allowing detection of small, but statistically significant, differences in polynucleotide copy number.
    Type: Application
    Filed: September 22, 2014
    Publication date: January 29, 2015
    Inventors: Benjamin Hindson, Serge Saxonov, Philip Belgrader, Kevin Ness, Michael Lucero, Billy Colston
  • Publication number: 20140357513
    Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.
    Type: Application
    Filed: July 14, 2014
    Publication date: December 4, 2014
    Inventors: Michael Lucero, Marc Unger
  • Patent number: 8828661
    Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: September 9, 2014
    Assignee: Fluidigm Corporation
    Inventors: Michael Lucero, Marc Unger
  • Patent number: 8828663
    Abstract: Devices and methods for performing the relative concentration of a target in a sample, the sample containing both target and non-target components, the method performed by partitioning the sample into a large number of reaction volumes such that the target is concentrated relative to the non-target, and performing a detection assay upon each reaction volume to detect the target.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: September 9, 2014
    Assignees: Fluidigm Corporation, The Regents of the University of California
    Inventors: Marc Unger, Lincoln McBride, Geoffrey Facer, Michael Lucero, Hany Ramez Nassef
  • Publication number: 20130171633
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: July 12, 2012
    Publication date: July 4, 2013
    Applicant: Fluidigm Corporation
    Inventors: Lincoln McBride, Geoffrey Facer, Marc Unger, Michael Lucero, Hany Ramez Nassef
  • Publication number: 20130065773
    Abstract: A variety of elastomeric-based microfluidic devices and methods for using and manufacturing such devices are provided. Certain of the devices have arrays of reaction sites to facilitate high throughput analyses. Some devices also include reaction sites located at the end of blind channels at which reagents have been previously deposited during manufacture. The reagents become suspended once sample is introduced into the reaction site. The devices can be utilized with a variety of heating devices and thus can be used in a variety of analyses requiring temperature control, including thermocycling applications such as nucleic acid amplification reactions, genotyping and gene expression analyses.
    Type: Application
    Filed: April 4, 2012
    Publication date: March 14, 2013
    Applicant: Fluidigm Corporation
    Inventors: Marc Unger, Ian D. Manger, Michael Lucero, Yong Yi, Emily Miyashita-Lin, Anja Wienecke, Geoffrey Facer
  • Patent number: 8343442
    Abstract: A variety of elastomeric-based microfluidic devices and methods for using and manufacturing such devices are provided. Certain of the devices have arrays of reaction sites to facilitate high throughput analyses. Some devices also include reaction sites located at the end of blind channels at which reagents have been previously deposited during manufacture. The reagents become suspended once sample is introduced into the reaction site. The devices can be utilized with a variety of heating devices and thus can be used in a variety of analyses requiring temperature control, including thermocycling applications such as nucleic acid amplification reactions, genotyping and gene expression analyses.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: January 1, 2013
    Assignee: Fluidigm Corporation
    Inventors: Lincoln McBride, Michael Lucero, Marc Unger, Hany Ramez Nassef, Geoffrey Facer
  • Publication number: 20120252015
    Abstract: The present disclosure provides methods and compositions for detecting polynucleotides in a sample and for quantifying polynucleotide load in a sample. The polynucleotides can be associated with a disease, disorder, or condition. In some applications, methylated DNA is quantified, e.g., in order to determine the load of polynucleotides in a sample. The present disclosure also provides methods and compositions for determining the load of fetal polynucleotides in a biological sample, e.g., the load of fetal polynucleotides (e.g., DNA, RNA) in maternal plasma. The present disclosure provides methods and compositions for detecting cellular processes such as cellular viability, growth rates, and infection rates. This disclosure also provides compositions and methods for detecting differences in copy number of a target polynucleotide. In some embodiments, the methods and compositions provided herein are useful for diagnosis of fetal genetic abnormalities, when the starting sample is maternal tissue (e.g.
    Type: Application
    Filed: February 17, 2012
    Publication date: October 4, 2012
    Applicant: Bio-Rad Laboratories
    Inventors: Benjamin Hindson, Serge Saxonov, Philip Belgrader, Kevin Ness, Michael Lucero, Billy Colston, Shawn Paul Hodges, Nicholas J. Heredia, Jeffrey Clark Mellen, Camille Bodley Troup, Paul Wyatt
  • Patent number: D941763
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: January 25, 2022
    Assignee: Six to Six Technologies, LLC
    Inventors: Michael Lucero Pena, Iuliu Cosmin Gordea